Biotech veteran Alexis Borisy thinks he can undersell the drug industry. Here’s the idea: Borisy is starting a company to develop drugs that copy the drugs that biopharma companies are making and sell them for about a third of what the competitor drugs are going for. These won’t be generic drugs. Instead, Borisy aims to make fast followers-unique medications, protected by their own patents, that copy a drug or class of drugs. Borisy’s will hit the market just a few years after their competitors at a fraction of the price. The new company is called EQRx, and is being unveiled this week. Learn More